CN113768928B - Instant nano-scale biotin microcapsule and preparation method and application thereof - Google Patents

Instant nano-scale biotin microcapsule and preparation method and application thereof Download PDF

Info

Publication number
CN113768928B
CN113768928B CN202111136798.9A CN202111136798A CN113768928B CN 113768928 B CN113768928 B CN 113768928B CN 202111136798 A CN202111136798 A CN 202111136798A CN 113768928 B CN113768928 B CN 113768928B
Authority
CN
China
Prior art keywords
biotin
oil
microcapsule
nano
scale
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111136798.9A
Other languages
Chinese (zh)
Other versions
CN113768928A (en
Inventor
魏初权
刘锦洪
王文积
林木荣
王雪瑞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiamen Kingdomway Biotechnology Co ltd
Xiamen Kingdomway Group Co
Original Assignee
Xiamen Kingdomway Biotechnology Co ltd
Xiamen Kingdomway Group Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen Kingdomway Biotechnology Co ltd, Xiamen Kingdomway Group Co filed Critical Xiamen Kingdomway Biotechnology Co ltd
Priority to CN202111136798.9A priority Critical patent/CN113768928B/en
Publication of CN113768928A publication Critical patent/CN113768928A/en
Application granted granted Critical
Publication of CN113768928B publication Critical patent/CN113768928B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A23L29/04—Fatty acids or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/045—Organic compounds containing nitrogen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the technical field of biotin, and particularly relates to an instant nano-scale biotin microcapsule as well as a preparation method and application thereof. The instant nano-scale biotin microcapsule comprises a capsule core and a capsule wall material, wherein the capsule core is coated in the capsule wall material, the capsule core contains 5-15% of biotin crystals, 20-30% of carrier oil and 0.5-1.5% of oil phase emulsifier by taking the total weight of the instant nano-scale biotin microcapsule as a reference, the capsule wall material contains 20-40% of water phase emulsifying wall materials, 10-50% of micromolecular fillers, 2-5% of cosolvent and 0.5-1.5% of stabilizing agents, the crystal grain size of the biotin crystals is less than or equal to 100nm, and the molecular weight of the micromolecular fillers is less than or equal to 1000. The nano-scale biotin microcapsule provided by the invention is instant, has strong acid resistance and good dissolution and reconstitution properties, is beneficial to intestinal absorption, and has high bioavailability.

Description

Instant nano-scale biotin microcapsule and preparation method and application thereof
Technical Field
The invention belongs to the technical field of biotin, and particularly relates to an instant nano-scale biotin microcapsule as well as a preparation method and application thereof.
Background
Biotin (Biotin), also known as vitamin H and Coenzyme R (Coenzyme R), is a water-soluble vitamin, also belongs to the vitamin B group, specifically vitamin B7, which is an essential substance for the synthesis of vitamin C, is an indispensable substance for the normal metabolism of fats and proteins, and is a nutrient necessary for maintaining the natural growth, development and normal functional health of the human body. Biotin was a factor found in the liver in the study of growth factors of yeast and growth and respiration-promoting factors of rhizobia in the 30 th 20 th century and was a factor that can prevent and treat depilation and skin damage in rats induced by feeding raw egg protein. Biotin is easily bound to one of the chicken proteins, and a large amount of dietary raw protein can prevent absorption of biotin, resulting in biotin deficiency, such as alopecia, weight loss, dermatitis, etc. Biotin plays an important role in biochemical reaction pathways such as fat synthesis and carbohydrate regeneration. Biotin is a saving star of baldness, has a good effect on preventing hair loss and light on the top of the head, and can also prevent the common juvenile canities of modern people. It also plays an important role in maintaining skin health, and is beneficial to depression and insomnia.
Biotin is colorless needle crystal, is very slightly soluble in water (22 mg/100mL water, 25 deg.C) and ethanol (80 mg/100mL,25 deg.C), is insoluble in other common organic solvents, is stable to heat, and can be destroyed by strong acid, strong base and oxidant, and can be gradually destroyed by ultraviolet ray. Biotin is mainly stored in the liver and is present in the blood at a low level. The biotin in the food exists mainly in a free form or a form combined with protein, and the biotin combined with the protein forms biocytin under the action of intestinal protease, and then releases the free biotin through the action of intestinal biotinidase. The main part of biotin absorption is the proximal end of the small intestine, and the biotin is actively absorbed by carrier transport at low concentration; at high concentration, biotin is absorbed in a simple diffusion mode, absorbed biotin is circulated through portal vessels and transported to the liver and kidney for storage, and other cells also contain biotin but in a small amount. Human intestinal bacteria can synthesize biotin from diopimelic acid instead of pelargonic acid, but the direct source of biotin is not enough. Most of biotin products in the market are pure products or pure products and other auxiliary materials are simply mixed for use, the bioavailability is low, and the improvement of the bioavailability becomes the direction of the current industry exploration.
Although patent documents and non-patent documents are commonly reported about biotin application and synthesis methods, no reports about biotin microencapsulation technology are found, because biotin is non-fat-soluble and is very slightly soluble in water (22 mg/100mL water, 25 ℃) although being a water-soluble vitamin, and has low solubility in hot water and high difficulty in microencapsulation, and thus no reports about biotin microencapsulation technology are found at present.
Disclosure of Invention
The invention aims to overcome the defect of low bioavailability of the conventional biotin product, and provides a quick-dissolving nano-scale biotin microcapsule capable of improving the bioavailability as well as a preparation method and application thereof.
After intensive research, the inventor of the present invention finds that the main reason for the low bioavailability of the biotin products in the market, which are used in the form of pure products or pure products simply mixed with other auxiliary materials, is that: on one hand, the biotin crystal particles in the biotin products are large, poor in dissolving and dissolving performance and poor in stability, and are difficult to absorb and utilize by organisms; on the other hand, the biotin products are not resistant to strong acidity, the pH value of gastric juice is 0.9-1.8 (strong acidity), the pH value of small intestine liquid is 8.0-9.0 (alkalinity), the main part of biotin absorption is small intestine, and when the biotin is taken in a pure product or a simple mixed form of the pure product and other auxiliary materials, the biotin is destroyed in the strong acidic gastric juice and can not effectively reach the intestinal tract, so that the bioavailability is low, and the health care or treatment effect is poor.
After intensive research, the inventor of the invention finds that after the biotin is prepared into the microcapsule powder, the solubility of the biotin can be improved, the biotin is protected from the destructive effect of strong acid in the gastrointestinal tract, and the absorption of the biotin is enhanced. However, as mentioned above, no key reason for the reports on the biotin microencapsulation technology is found at present, because the unique property of non-fat solubility and very slight water solubility of biotin makes the microencapsulation difficult. In the process of biotin microencapsulation, non-fat-soluble biotin which is extremely slightly dissolved in water is dispersed in carrier oil in the presence of an oil phase emulsifier and is firstly prepared into oil suspension of nano microcrystals through nano grinding treatment, and then the oil suspension is prepared into microcapsule powder through microencapsulation embedding by adopting a low-temperature emulsification method, so that the effective coating of the biotin microcrystals can be realized, the solubility of the biotin can be effectively improved, the biotin is protected from the destructive effect of strong acid in gastrointestinal tracts, and the bioavailability of the biotin can be enhanced. Based on this, the present invention has been completed.
The invention specifically provides an instant nano-scale biotin microcapsule, which comprises a capsule core and a capsule wall material, wherein the capsule core is coated in the capsule wall material, the capsule core contains 5-15% of biotin crystals, 20-30% of carrier oil and 0.5-1.5% of oil phase emulsifier by taking the total weight of the instant nano-scale biotin microcapsule as a reference, the capsule wall material contains 20-40% of water phase emulsifying wall material, 10-50% of small molecule filler, 2-5% of cosolvent and 0.5-1.5% of stabilizer, the crystal grain size of the biotin crystals is less than or equal to 100nm, and the molecular weight of the small molecule filler is less than or equal to 1000.
Further, the carrier oil is a vegetable oil and/or a fatty acid ester.
Further, the vegetable oil is at least one selected from corn oil, soybean oil, peanut oil, olive oil, sesame oil, sunflower oil, safflower oil, linseed oil, castor oil, cottonseed oil, hemp oil, sesame oil, linseed oil, sasanqua oil, peony seed oil, palm oil, walnut oil, coconut oil, rice oil and rapeseed oil.
Further, the fatty acid ester is selected from at least one of caproic acid triglyceride, caprylic acid triglyceride, capric acid triglyceride, caprylic acid triglyceride, heptanoic acid triglyceride and lauric acid triglyceride.
Further, the oil phase emulsifier is at least one of sucrose ester with HLB value of 5-7, vitamin E polyethylene glycol succinate, glyceride and lecithin.
Further, the water phase emulsifying wall material is at least one selected from modified starch, arabic gum, whey protein, sodium caseinate and isolated soy protein, and is preferably modified starch.
Further, the modified starch is selected from at least one of acid-modified starch, starch octenyl succinate, starch sodium octenyl succinate, oxidized starch, starch acetate, hydroxypropyl starch, and pregelatinized starch.
Further, the small molecular filler is selected from at least one of monosaccharide, disaccharide and oligosaccharide with the molecular weight of 150-500, preferably at least one of glucose, maltose, sucrose, maltodextrin, solid corn syrup and resistant dextrin.
Further, the cosolvent is at least one selected from glycerol, sorbitol, mannitol and hexaglycerol laurate.
Further, the stabilizer is selected from at least one of sodium hexametaphosphate, potassium tripolyphosphate, trisodium citrate, ethylene diamine tetraacetic acid and sodium salts thereof, ascorbic acid and sodium salts thereof.
Furthermore, the instant nano-scale biotin microcapsule also contains pigment and/or essence, wherein oil-soluble components in the pigment and the essence are distributed in the capsule core, and water-soluble components in the capsule wall are distributed in the capsule wall material.
Further, the particle size D of the instant nano-scale biotin microcapsule 90 300 to 500 mu m.
Further, after 1g of the instant nano-scale biotin microcapsule is dissolved in 100mL of normal-temperature water, the particle size distribution D of oil drops in the emulsion is obtained 10 ≤0.15μm，D 50 ≤0.5μm，D 90 ≤1μm。
The invention also provides a preparation method of the instant nano-scale biotin microcapsule, which comprises the following steps:
s1, stirring and dispersing biotin crystals, an oil phase emulsifier and optional oil-soluble components in pigments and/or essences and fragrances in carrier oil, then grinding until the particle size of the crystals of the biotin crystals is less than or equal to 100nm, and then cooling the system to 0-20 ℃ to obtain an oil suspension I;
s2, stirring and dissolving water-soluble components in the water-phase emulsification wall material, the small-molecule filler, the cosolvent, the stabilizer and the optional pigment and/or essence perfume in water at 50-60 ℃, and then cooling the system to 0-20 ℃ to obtain a water phase II;
s3, mixing and homogenizing the oil suspension I and the water phase II at 0-20 ℃, and adjusting the viscosity to 100-350 mPa & S to obtain an emulsion;
and S4, carrying out spray drying on the emulsion to obtain the instant nano-scale biotin microcapsule.
Further, in the step S3, the oil suspension I and the water phase II are mixed in a homogenizing manner, and then the system temperature is controlled to be 0-20 ℃ and the shearing rotating speed is controlled to be 8000-12000 r/min for shearing emulsification for 10-30 min so as to ensure that the grain diameter D of the oil drops 90 Less than or equal to 2 mu m, and then homogenizing for 2 to 3 times under the high pressure of 30 to 60MPa to ensure that the grain diameter D of oil drops 90 ≤1μm。
Further, in step S4, the spray drying conditions include an inlet air temperature of 100-180 ℃, an outlet air temperature of 50-90 ℃, and an inlet air volume of 20-30 m 3 The pressure of the spray tower is 0.1-0.5 KPa.
Furthermore, the preparation method of the instant nano-scale biotin microcapsule provided by the invention also comprises the step of adding an anticaking agent into the instant nano-scale biotin microcapsule after spray drying.
Further, the anti-caking agent is selected from at least one of silicon dioxide, tricalcium phosphate, calcium silicate and microcrystalline cellulose.
Further, the dosage of the anticaking agent is not more than 1wt% of the mass of the instant nano-scale biotin microcapsule.
The invention also provides application of the instant nano-scale biotin microcapsule as a food additive or a medicine.
The key point of the invention is that the biotin is made into the microcapsule by adopting a specific microencapsulation technology, specifically, the biotin crystal particles are dispersed in carrier oil and are firstly made into oil suspension of nano microcrystals through nano grinding treatment, and then the oil suspension is microencapsulated and embedded by adopting a low-temperature emulsification method to prepare microcapsule powder, so that the obtained microcapsule has better solubility and acid resistance, can protect the biotin from the destructive effect of strong acid in stomach, can effectively reach the small intestine to be effectively absorbed, enhances the bioavailability of the biotin and can directly carry related components to enter blood. The instant nano-scale biotin microcapsule provided by the invention has a wide pH application range, can be used at a pH value of 1-14, and expands the application field of biotin products. In addition, the invention adopts a low-temperature emulsification method to prepare the instant nano-scale biotin microcapsule, can effectively prevent biotin from being dissolved by water phase in the microencapsulation process, effectively microencapsulates biotin microcrystals, and adds a cosolvent and a stabilizer in the microencapsulation process, thereby remarkably improving the solubility, the reconstitution property and the strong acid resistance of the biotin microcapsule.
The nano-scale biotin microcapsule obtained by the method has uniform content, can be mixed with water in any proportion, is instant, has acid resistance and good dissolution and reconstitution properties, can form uniform and stable solution, has high stability, can obviously inhibit crystallization of biotin, is beneficial to intestinal absorption, has high bioavailability, can improve intestinal transmission of nutrient components and provide a protection effect, can be added into systems such as foods, medicines and the like only according to the required amount in the application process, and is extremely convenient to use.
Detailed Description
In the invention, the instant nano-scale biotin microcapsule comprises a capsule core and a capsule wall material, wherein the capsule core is coated in the capsule wall material. Wherein the capsule core contains biotin crystals, carrier oil and an oil phase emulsifier. The capsule wall material contains an aqueous phase emulsification wall material, a small molecular filler, a cosolvent and a stabilizer. The speed isParticle diameter D of soluble nano-scale biotin microcapsule 90 Preferably 300 to 500. Mu.m. Furthermore, it is preferable that 1g of the instant nano-scale biotin microcapsules is dissolved in 100mL of water at normal temperature to obtain an emulsion having a particle size distribution D of oil droplets 10 ≤0.15μm，D 50 ≤0.5μm，D 90 ≤1μm。
The crystal size of biotin in the capsule core is nanometer, and is less than or equal to 100nm, such as 5nm, 10nm, 15nm, 20nm, 25nm, 30nm, 35nm, 40nm, 45nm, 50nm, 55nm, 60nm, 65nm, 70nm, 75nm, 80nm, 85nm, 90nm, 95nm, and 100nm. The content of the biotin crystals is 5 to 15%, and may be, for example, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%.
The carrier oil in the capsule core plays a role in suspending and dispersing the biotin crystals so as to facilitate grinding the biotin crystals to a nanometer level. The carrier oil may be a vegetable oil and/or a fatty acid ester. The vegetable oil may be natural vegetable oil, or vegetable oil obtained by structural modification and hydrolysis, or a mixture thereof, and specifically may be at least one selected from corn oil, soybean oil, peanut oil, olive oil, sesame oil, sunflower seed oil, safflower oil, linseed oil, castor oil, cottonseed oil, hemp oil, linseed oil, camellia oil, peony seed oil, palm oil, walnut oil, coconut oil, rice oil, rapeseed oil, and the like. The fatty acid ester may be at least one of caproic acid triglyceride, caprylic acid triglyceride, capric acid triglyceride, caprylic acid triglyceride (MCT), enanthic acid triglyceride and lauric acid triglyceride, preferably caprylic acid triglyceride (MCT). The carrier oil has excellent mutual solubility, dilution and emulsification solubilization, can realize effective dispersion of biotin crystals, has extremely high oxidation resistance, and can avoid the change of color and smell of vegetable oil caused by rancidity. In addition, the carrier oil can be rapidly digested and absorbed without the hydrolysis of pancreatic lipase and without the participation of lymphatic system in absorption, and can promote the absorption of biotin. The content of the carrier oil is 20 to 30%, and for example, may be 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%.
The use of an oil phase emulsifier in the core ensures that a stable emulsion is formed during microencapsulation. The oil phase emulsifier may be at least one of sucrose ester having an HLB value of 5 to 7, vitamin E polyethylene glycol succinate, glyceride, and lecithin, for example. Specific examples of the sucrose esters include, but are not limited to: sucrose acetate isobutyrate, sucrose fatty acid ester, sucrose laurate, and the like. The average molecular weight of the polyethylene glycol in the vitamin E polyethylene glycol succinate may be 200 to 8000, specifically, PEG200, PEG400, PEG800, PEG1000, PEG2000, PEG4000, PEG8000, and the like, and is not particularly limited. The glyceride may be at least one of stearic acid monoglyceride, lauric acid monoglyceride, citric acid monoglyceride, succinic acid monoglyceride, oleic acid monoglyceride, palmitic acid monoglyceride, and the like. The content of the oil phase emulsifier is 0.5 to 1.5%, and may be, for example, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%.
Specific examples of the water phase emulsifying wall material in the capsule material include, but are not limited to: at least one of modified starch, gum arabic, whey protein, sodium caseinate and soy protein isolate, preferably modified starch. The modified starch is preferably at least one selected from acid-modified starch, starch octenylsuccinate, starch sodium octenylsuccinate, oxidized starch, starch acetate, hydroxypropyl starch and pregelatinized starch, and the modified starch can be obtained commercially or prepared by the existing method, and the specific preparation process is well known to those skilled in the art and is not described herein. The content of the aqueous emulsification wall material may be 20 to 40%, for example, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%.
The micro-molecular filler in the capsule wall material plays a role in filling micro-pores on the surface of the microcapsule, and the surface of the microcapsule can be more compact due to the good film-forming property, so that a capsule core substance (biotin) is effectively protected, and the risk that the capsule core is damaged by external conditions is reduced. The molecular weight of the small molecule filler is less than or equal to 1000, for example, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, preferably 150 to 500. The small molecule filler is preferably a low molecule saccharide substance, and specifically may be at least one of monosaccharide, disaccharide and oligosaccharide, and specific examples thereof include but are not limited to: at least one of glucose, maltose, sucrose, maltodextrin, solid corn syrup, and resistant dextrin. The content of the small molecule filler is 10 to 50%, for example, 10%, 12%, 15%, 18%, 20%, 22%, 25%, 28%, 30%, 32%, 35%, 37%, 40%, 42%, 45%, 48%, 50%.
The cosolvent in the capsule wall material has the functions of assisting the dissolution and dispersion of the biotin microcapsules in water, promoting the dissolution performance of the biotin microcapsules in water, and inhibiting the crystallization phenomenon of biotin after the biotin microcapsules are dissolved in water, so that the absorption of the biotin by intestinal tracts is facilitated, and the bioavailability of the biotin is improved. Specific examples of such co-solvents include, but are not limited to: at least one of glycerin, sorbitol, mannitol, and hexaglycerol laurate. The content of the cosolvent is 2 to 5%, and for example, may be 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%.
The stabilizing agent in the capsule wall material has the functions of improving the stability of the biotin microcapsules, and inhibiting the crystallization phenomenon of the biotin after the biotin microcapsules are dissolved in water, so that the absorption of the biotin by intestinal tracts is facilitated, and the bioavailability of the biotin is improved. Specific examples of the stabilizer include, but are not limited to: at least one of sodium hexametaphosphate, potassium tripolyphosphate, trisodium citrate, ethylene diamine tetraacetic acid and sodium salts thereof, ascorbic acid and sodium salts thereof. The content of the stabilizer is 0.5 to 1.5%, and may be, for example, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%.
The instant nano-scale biotin microcapsule also contains pigment and/or essence and flavor, and is used for improving the color, the fragrance and the taste of the microcapsule. The types of the pigment and the essence and flavor are allowed to be used in the food field or the pharmaceutical field, the specific types can be selected conventionally in the field, and the addition amount is also the conventional addition amount allowed to be used in the food field or the pharmaceutical field, and is known to those skilled in the art, and the details are not described herein. The distribution of the pigment and the essence perfume in the microcapsule depends on the hydrophilic and lipophilic characteristics of the microcapsule, and the oil-soluble components in the pigment and the essence perfume are distributed in the capsule core and the water-soluble components in the capsule wall material.
The preparation method of the instant nano-scale biotin microcapsule provided by the invention comprises the following steps:
s1, stirring and dispersing biotin crystals, an oil phase emulsifier and optional oil-soluble components in pigments and/or essences and fragrances in carrier oil, then grinding until the particle size of the crystals of the biotin crystals is less than or equal to 100nm, and then cooling the system to 0-20 ℃ to obtain an oil suspension I;
s2, stirring and dissolving water-soluble components in the water-phase emulsification wall material, the small-molecule filler, the cosolvent, the stabilizer and the optional pigment and/or essence perfume in water at 50-60 ℃, and then cooling the system to 0-20 ℃ to obtain a water phase II;
s3, mixing and homogenizing the oil suspension I and the water phase II at 0-20 ℃, and adjusting the viscosity to 100-350 mPa & S to obtain an emulsion;
and S4, carrying out spray drying on the emulsion to obtain the instant nano-scale biotin microcapsule.
In step S1, the biotin crystallization raw material can be obtained commercially, and the crystal grain size is generally more than or equal to 50 μm. The stirring dispersion is only required to be capable of approximately dispersing the biotin crystals, the oil-phase emulsifier and optionally the oil-soluble component in the pigment and/or the essence in the carrier oil. The grinding may be carried out in various existing nano-sand mills under conditions that can reduce the crystal particle size of the biotin crystals to 100nm or less.
In step S3, the mixing and homogenizing method is not particularly limited as long as the oil suspension I and the water phase II can be sufficiently emulsified to form an emulsionPreferably, the oil suspension I and the water phase II are mixed, and then the system temperature is controlled to be 0-20 ℃ and the shearing rotating speed is controlled to be 8000-12000 r/min for shearing emulsification for 10-30 min so as to ensure that the oil drop diameter D 90 Less than or equal to 2 mu m, and then homogenizing for 2 to 3 times under the high pressure of 30 to 60MPa to ensure that the grain diameter D of oil drops 90 Less than or equal to 1 mu m. The reason why the mixing and homogenization are carried out at 0 to 20 ℃ is mainly that the probability that the biotin crystals are dissolved in the aqueous phase can be reduced as much as possible by carrying out the mixing and homogenization at a lower temperature of 0 to 20 ℃ in consideration of the fact that biotin is very slightly soluble in water (22 mg/100mL of water, 25 ℃), so that the biological crystals are coated in the capsule material as much as possible. In addition, the viscosity needs to be adjusted to 100 to 350mPa · s after the mixing and homogenization in order to enable the emulsion to be smoothly carried out in the subsequent spray drying process and achieve a good coating effect. In the present invention, the viscosity is measured using an Ubbelohde viscometer.
In step S4, the conditions of the spray drying preferably include that the air inlet temperature is 100-180 ℃, the air outlet temperature is 50-90 ℃, and the air inlet volume is 20-30 m 3 The pressure of the spray tower is 0.1-0.5 KPa. In the present invention, the pressures are gauge pressures.
In another preferred embodiment, the method for preparing the instant nano-scale biotin microcapsules further comprises adding an anti-caking agent to the instant nano-scale biotin microcapsules after spray-drying, wherein agglomeration between the microcapsules can be effectively prevented. The anticaking agent may be at least one selected from the group consisting of silicon dioxide, tricalcium phosphate, calcium silicate, and microcrystalline cellulose. In addition, the amount of the anti-caking agent is preferably not more than 1wt% of the mass of the instant nano-scale biotin microcapsule.
In the preparation process of the instant nano-scale biotin microcapsule, the types and the amounts of the raw materials are described above, and are not described herein again.
The invention also provides application of the instant nano-scale biotin microcapsule as a food additive or a medicine.
In the following examples and comparative examples, the parts of the components used are by weight unless otherwise specified.
In the following examples and comparative examples, the content of biotin in the microcapsules was measured by HPLC, and the column was VP-ODS (4.6 mm. Times.250mm, 5 μm); the mobile phase was acetonitrile-phosphoric acid-0.05% trifluoroacetic acid (volume ratio 250; the detector is an ultraviolet detector; the detection wavelength is 210nm; the column temperature is room temperature; the flow rate is 1.0mL/min; the amount of sample was 20. Mu.L.
Example 1
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 10
Caprylic capric acid glyceride (MCT) 25
Stearic acid monoglyceride 1
Starch sodium octenyl succinate 30
Sucrose 30.5
Glycerol 2
Ascorbic acid sodium salt 1.5
S1, adding 10 parts of biotin crystals and 1 part of glycerol monostearate into 25 parts of MCT oil, stirring and dispersing uniformly, grinding by using a nano sand mill to enable the biotin crystals to reach nano-scale particles (less than 100 nm), cooling to 20 ℃ by using cooling water to prepare an oil suspension I for later use.
S2, adding 30 parts of sodium starch octenylsuccinate, 30.5 parts of sucrose, 2 parts of glycerol and 1.5 parts of sodium ascorbate into 110 parts of pure water, heating to 50-60 ℃, stirring until the sodium starch is completely dissolved, and cooling to 20 ℃ by using cooling water to obtain a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying for 15min at the temperature of 20 ℃ and the rotating speed of 10000rpm to ensure that the particle size D of oil drops 90 Less than or equal to 2 microns, then homogenizing for 2 times under 50MPa, and detecting to obtain the oil drop grain diameter D of the high-pressure homogenized product 90 Then, the viscosity of the emulsion was adjusted to 0.862 μm and 250 mPas, to obtain a biotin emulsion.
S4, spray drying the biotin emulsion, wherein the air inlet temperature is set to 170 ℃, the air outlet temperature is set to 80 ℃, and the air inlet volume is set to 30m 3 The pressure of the spray tower is 0.4KPa, and the biotin microcapsule (particle diameter D) is obtained 90 300 μm), 0.5 part of silica was mixed as an anticaking agent. The content of biotin in the microcapsules was 9.75% by HPLC.
Example 2
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 5
Caprylic capric acid glyceride (MCT) 20
Stearic acid monoglyceride 0.5
Starch sodium octenyl succinate 20
Maltodextrin 50
Sorbitol 3
Sodium hexametaphosphate 1.5
S1, adding 5 parts of biotin crystals and 0.5 part of glycerol monostearate into 20 parts of MCT oil, stirring and dispersing uniformly, grinding by using a nano sand mill to enable the biotin crystals to reach nano-scale particles (less than 100 nm), cooling to 15 ℃ by using cooling water to prepare an oil suspension I for later use.
S2, adding 20 parts of sodium starch octenyl succinate, 50 parts of maltodextrin, 3 parts of sorbitol and 1.5 parts of sodium hexametaphosphate into 110 parts of pure water, heating to 50-60 ℃, stirring until the sodium starch hexametaphosphate is completely dissolved, and cooling to 15 ℃ by using cooling water to obtain a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying for 15min at the temperature of 15 ℃ and the rotating speed of 11000rpm to ensure that the grain diameter D of oil drops 90 Less than or equal to 2 mu m, then homogenizing for 2 times under the high pressure of 60MPa, and detecting to obtain the oil drop grain diameter D of the high-pressure homogenized product 90 Then, the viscosity of the emulsion was adjusted to 200 mPas to obtain a biotin emulsion, which was 0.756 μm.
S4, mixingSpray drying the biotin emulsion, setting the air inlet temperature at 165 ℃, the air outlet temperature at 75 ℃ and the air inlet amount at 30m 3 The pressure of the spray tower is 0.4KPa, and the biotin microcapsule (particle diameter D) is obtained 90 350 μm) was mixed with 0.8 part of tricalcium phosphate as an anticaking agent. The content of biotin in the microcapsules was 4.85% as determined by high performance liquid chromatography.
Example 3
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 15
Corn oil 30
Lauric acid monoglyceride 1.5
Arabic gum 40
Solid corn syrup 10
Mannitol 3
Citric acid trisodium salt 0.5
S1, adding 15 parts of biotin crystals and 1.5 parts of lauric acid monoglyceride into 30 parts of corn oil, stirring and dispersing uniformly, then grinding by using a nano sand mill to enable the biotin crystals to reach nano-scale particles (less than 100 nm), and cooling to 20 ℃ by using cooling water to prepare an oil suspension I for later use.
S2, adding 40 parts of Arabic gum, 10 parts of solid corn syrup, 3 parts of mannitol and 0.5 part of trisodium citrate into 110 parts of pure water, heating to 50-60 ℃, stirring until the materials are completely dissolved, and cooling to 20 ℃ with cooling water to prepare a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying at the temperature of 20 ℃ and the rotating speed of 9000rpm for 20min to enable the oil drop particle size D 90 Less than or equal to 2 microns, high-pressure homogenizing for 3 times under 55MPa, and detecting to obtain oil drop particle diameter D 90 Then, the emulsion viscosity was adjusted to 220 mPas to 0.776 μm to obtain a biotin emulsion.
S4, spray drying the biotin emulsion, wherein the air inlet temperature is set to be 160 ℃, the air outlet temperature is set to be 75 ℃, and the air inlet volume is set to be 30m 3 The pressure of the spray tower is 0.4KPa, and the biotin microcapsule (particle diameter D) is obtained 90 400 μm), 0.7 part of calcium silicate was mixed as an anticaking agent. The content of biotin in the microcapsules was 14.75% by HPLC.
Example 4
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 10
Corn oil 25
Lauric acid monoglyceride 1
Arabic gum 35
Solid corn syrup 23
Hexapolyglycerol laurate 5
Trisodium citrate 1
S1, adding 10 parts of biotin crystals and 1 part of lauric acid monoglyceride into 25 parts of corn oil, uniformly stirring and dispersing, then grinding by a nano sand mill to enable biotin crystals to reach nano-scale particles (less than 100 nm), cooling to 18 ℃ by cooling water to obtain an oil suspension I for later use.
S2, adding 35 parts of Arabic gum, 23 parts of solid corn syrup, 5 parts of hexa-polyglycerol laurate and 1 part of trisodium citrate into 110 parts of pure water, heating to 50-60 ℃, stirring until the materials are completely dissolved, and cooling to 18 ℃ by using cooling water to obtain a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying for 12min at the temperature of 18 ℃ and the rotating speed of 10000rpm to ensure that the particle size D of oil drops 90 Less than or equal to 2 microns, then homogenizing for 2 times under 50MPa, and detecting to obtain the oil drop grain diameter D of the high-pressure homogenized product 90 Then, the viscosity of the emulsion was adjusted to 250 mPas to 0.766 μm, thereby obtaining a biotin emulsion.
S4, carrying out spray drying on the biotin emulsion, and setting the air inlet temperature to be 16 DEGThe air outlet temperature is 80 ℃ and the air inlet quantity is 30m at 5 DEG C 3 The pressure of the spray tower is 0.4KPa, and the biotin microcapsule (particle diameter D) is obtained 90 500 μm) was added with 0.5 part of silica as an anticaking agent. The content of biotin in the microcapsules was 9.87% by HPLC.
Example 5
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 5
Soybean oil 20
Lauric acid monoglyceride 0.5
Casein sodium salt 20
Glucose 50
Glycerol 4
Ethylenediaminetetraacetic acid disodium salt 0.5
S1, adding 5 parts of biotin crystals and 0.5 part of lauric acid monoglyceride into 20 parts of soybean oil, stirring and dispersing uniformly, grinding by using a nano sand mill to enable biotin crystals to reach nano-scale particles (less than 100 nm), cooling to 15 ℃ by using cooling water to prepare an oil suspension I for later use.
S2, adding 20 parts of sodium caseinate, 50 parts of glucose, 4 parts of glycerol and 0.5 part of sodium ethylene diamine tetracetate into 100 parts of pure water, heating to 50-60 ℃, stirring until the sodium caseinate, the glucose, the glycerol and the sodium ethylene diamine tetracetate are completely dissolved, and cooling to 15 ℃ by using cooling water to obtain a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying at the temperature of 15 ℃ and the rotating speed of 8500rpm for 25min to enable the oil drop particle size D 90 Less than or equal to 2 microns, then homogenizing for 2 times under 60MPa, and detecting to obtain the oil drop grain diameter D of the high-pressure homogenized product 90 Then, the emulsion viscosity was adjusted to 180 mPas to 0.665. Mu.m, to obtain a biotin emulsion.
S4, spray drying the biotin emulsion, wherein the air inlet temperature is set to be 160 ℃, the air outlet temperature is set to be 75 ℃, and the air inlet volume is set to be 30m 3 The pressure of the spray tower is 0.4KPa to obtain biotin microcapsules (particle diameter D) 90 450 μm), 0.7 part of microcrystalline cellulose was mixed as an anticaking agent. The content of biotin in the microcapsules was 4.82% as determined by high performance liquid chromatography.
Example 6
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 15
Soybean oil 30
Lauric acid monoglyceride 1.5
Casein acid sodium salt 40
Glucose 10
Sorbitol 2
Potassium tripolyphosphate 1.5
S1, adding 15 parts of biotin crystals and 1.5 parts of lauric acid monoglyceride into 30 parts of soybean oil, uniformly stirring and dispersing, grinding by using a nano sand mill to enable biotin crystals to reach nano-scale particles (less than 100 nm), and cooling to 16 ℃ by using cooling water to prepare an oil suspension I for later use.
S2, adding 40 parts of sodium caseinate, 10 parts of glucose, 2 parts of sorbitol and 1.5 parts of potassium tripolyphosphate into 100 parts of pure water, heating to 50-60 ℃, stirring until the sodium caseinate, the glucose, the sorbitol and the potassium tripolyphosphate are completely dissolved, and cooling to 16 ℃ with cooling water to obtain a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying at the temperature of 16 ℃ and the rotating speed of 9000rpm for 15min to ensure that the particle size D of oil drops 90 Less than or equal to 2 microns, high-pressure homogenizing for 3 times under 55MPa, and detecting to obtain oil drop particle diameter D 90 Then, the viscosity of the emulsion was adjusted to 190 mPas to 0.635. Mu.m, thereby obtaining a biotin emulsion.
S4, carrying out spray drying on the biotin emulsion, wherein the air inlet temperature is set to 165 ℃, the air outlet temperature is set to 80 ℃, and the air inlet volume is set to 30m 3 The pressure of the spray tower is 0.4KPa, and the obtained organismMicrocapsule of vegetable element (particle diameter D) 90 300 μm) was mixed with 0.8 part of tricalcium phosphate as an anticaking agent. The content of biotin in the microcapsules was 14.79% as determined by high performance liquid chromatography.
Example 7
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 5
Rapeseed oil 20
Sucrose ester (HLB value 5) 1
Whey protein 20
Resistant dextrins 48
Glycerol 5
Citric acid trisodium salt 1
S1, adding 5 parts of biotin crystals and 1 part of sucrose ester (HLB value of 5) into 20 parts of rapeseed oil, stirring and dispersing uniformly, then grinding by a nano sand mill to enable the biotin crystals to reach nano-particles (less than 100 nm), cooling to 12 ℃ by cooling water to prepare an oil suspension I for later use.
S2, adding 20 parts of whey protein, 48 parts of resistant dextrin, 5 parts of glycerol and 1 part of trisodium citrate into 100 parts of pure water, heating to 50-60 ℃, stirring until the materials are completely dissolved, cooling to 12 ℃ by using cooling water, and preparing a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying at the temperature of 12 ℃ and the rotating speed of 8000rpm for 30min to enable the grain diameter D of oil drops 90 Less than or equal to 2 microns, then homogenizing for 3 times under 45MPa, and detecting to obtain the oil drop grain diameter D of the high-pressure homogenized product 90 Then, the emulsion viscosity was adjusted to 185 mPas to 0.656. Mu.m, thereby obtaining a biotin emulsion.
S4, carrying out spray drying on the biotin emulsion, wherein the air inlet temperature is set to 165 ℃, the air outlet temperature is set to 80 ℃, and the air inlet volume is set to 30m 3 H, the pressure of the spray tower is 0.4KPa, and the biotin microcapsules (the particle diameter D) are prepared 90 380 μm) was added with 0.8 part of tricalcium phosphate as an anticaking agent. The content of biotin in the microcapsules was 4.88% as determined by high performance liquid chromatography.
Example 8
Formulation composition
Formulation components Batch charging quantity (parts)
Biotin crystal 10
Peanut oil 25
Vitamin E polyethylene glycol 2000 succinate 0.5
Isolated soy protein 35
Maltose 24
Hexapolyglycerol laurate 5
Ascorbic acid 0.5
S1, adding 10 parts of biotin crystals and 0.5 part of vitamin E polyethylene glycol 2000 succinate into 25 parts of peanut oil, stirring and dispersing uniformly, then grinding by a nano sand mill to enable the biotin crystals to reach nano-scale particles (less than 100 nm), cooling to 15 ℃ by cooling water to prepare an oil suspension I for later use.
S2, adding 35 parts of soybean protein isolate, 24 parts of maltose, 5 parts of hexaglycerol laurate and 0.5 part of ascorbic acid into 100 parts of pure water, heating to 50-60 ℃, stirring until the mixture is completely dissolved, and cooling to 15 ℃ by using cooling water to obtain a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, and then shearing and emulsifying at the temperature of 15 ℃ and the rotation speed of 10000rpm for 15min to enable the oil drop particle size D 90 Less than or equal to 2 microns, then homogenizing for 2 times under 55MPa, and detecting to obtain the oil drop grain diameter D of the high-pressure homogenized product 90 The viscosity of the emulsion was adjusted to 0.750. Mu.m, and then adjusted to 260 mPas, to obtain a biotin emulsion.
S4, spray drying the biotin emulsion, wherein the air inlet temperature is 170 ℃, the air outlet temperature is 80 ℃, and the air inlet volume is 30m 3 The pressure of the spray tower is 0.4KPa, and the biotin microcapsule (particle diameter D) is obtained 90 430 μm), 0.5 part of two is mixed inSilica is used as an anti-caking agent. The content of biotin in the microcapsules was 9.82% as determined by high performance liquid chromatography.
Example 9
Biotin microcapsules was prepared by the same procedure as in example 7, except that sucrose ester having HLB value of 5 was replaced with the same weight part of sucrose ester having HLB value of 7, and the conditions were the same as in example 7, to obtain biotin microcapsules having particle size D 90 Is 460 μm. The content of biotin in the microcapsules was 4.90% by high performance liquid chromatography.
Comparative example 1
Biotin microcapsules were prepared as in example 1, except that the biotin crystals and glyceryl monostearate were mixed in MCT oil and not ground by a nanomesh mill, as follows:
s1, adding 10 parts of biotin crystals and 1 part of glycerol monostearate into 25 parts of MCT oil, stirring and dispersing uniformly, and cooling to 20 ℃ by using cooling water to prepare an oil suspension I, wherein the crystal grain size of the biotin crystals is more than or equal to 50 microns for later use.
S2, adding 30 parts of sodium starch octenylsuccinate, 30.5 parts of sucrose, 2 parts of glycerol and 1.5 parts of sodium ascorbate into 110 parts of pure water, heating to 50-60 ℃, stirring until the sodium starch is completely dissolved, and cooling the water to 20 ℃ to obtain a water phase II for later use.
S3, mixing the oil suspension I and the water phase II, shearing and emulsifying at the temperature of 20 ℃ and the rotation speed of 10000rpm for 15min, then homogenizing at 50MPa for 2 times, and detecting to obtain the oil drop particle size D of the high-pressure homogenized product 90 And 55.5 μm (the actual particle diameter of the biotin crystal particles was measured), followed by adjusting the viscosity of the emulsion to 250 mPas to obtain a biotin emulsion.
S4, spray drying the biotin emulsion, wherein the air inlet temperature is set to 170 ℃, the air outlet temperature is set to 80 ℃, and the air inlet volume is set to 30m 3 The pressure of the spray tower is 0.4KPa, and the biotin microcapsule (particle diameter D) is obtained 90 430 μm), 0.5 parts of silica was mixed as an anticaking agent. The content of biotin in the microcapsules was 9.05% as determined by high performance liquid chromatography.
Comparative example 2
A biotin batch was prepared as in example 1, except that caprylin caprin (MCT) was replaced with the same weight parts of sucrose and the raw materials were simply physically mixed to form the biotin batch, specifically: fully and uniformly mixing 10 parts of biotin crystals, 1 part of glycerol monostearate, 30 parts of sodium starch octenylsuccinate, 55.5 parts of sucrose, 2 parts of glycerol and 1.5 parts of sodium ascorbate to obtain a biotin mixed material, mixing 0.5 part of silicon dioxide as an anti-caking agent, and detecting the content of biotin in the mixed material to be 8.45% by using a high performance liquid chromatograph.
Comparative example 3
A biotin batch was prepared as in example 1, except that caprylic capric acid glyceride (MCT) was replaced with the same weight parts of sucrose, and the biotin batch was prepared by completely dissolving the biotin crystals in hot water without embedding, and spray-drying after all the materials were dissolved together, specifically: adding 10 parts of biotin crystals into 110 parts of pure water, heating to 80-90 ℃ to completely dissolve the biotin crystals, adding 1 part of glycerol monostearate, 30 parts of sodium starch octenylsuccinate, 2 parts of glycerol, 55.5 parts of sucrose and 1.5 parts of sodium ascorbate, stirring for dissolving, and then carrying out spray drying, wherein the air inlet temperature is set to be 170 ℃, the air outlet temperature is set to be 80 ℃, and the air inlet amount is set to be 30m 3 At 0.4KPa in the spray tower pressure, biotin-containing mixture powder was obtained, and 0.5 part of silica was mixed as an anti-caking agent. The content of biotin in the powder was measured to be 9.45% by high performance liquid chromatography.
Comparative example 4
Biotin microcapsules were prepared by the method of example 1, except that the conditions for the nano-sand mill grinding in step S1 were controlled so that the particle size of the biotin crystals was 200 to 1000nm, and the other conditions were the same as in example 1, to obtain biotin microcapsules having a particle size D 90 And 390 μm. The content of biotin in the microcapsules was 9.15% as determined by high performance liquid chromatography.
Test example 1
The samples of examples 1 to 9 and comparative examples 1 to 4 were tested for solubility, specifically: the sample (1 g) was dissolved in 100mL of normal temperature water, and the time for the sample to completely settle in water (standing) and the dissolution of the aqueous solution were observed.
Table 1: table of solubility
Numbering Solubility in water
Example 1 The emulsion is uniform in 25s during dissolution
Example 2 The emulsion is uniform for 23s
Example 3 The emulsion is uniform in 25s during dissolution
Example 4 The emulsion is uniform in 24s during dissolution
Example 5 The emulsion is uniform in 24s during dissolution
Example 6 The emulsion is uniform for 23s
Example 7 The emulsion is uniform for 21s
Example 8 26s when dissolved, the emulsion is uniform
Example 9 The emulsion is uniform within 22s when dissolved
Comparative example 1 It can not be completely dissolved within 20min, the emulsion has obvious particles, and insoluble substances precipitate at the bottom
Comparative example 2 It can not be completely dissolved within 20min, the emulsion has obvious particles, and insoluble substances precipitate at the bottom
Comparative example 3 It can not be completely dissolved within 20min, the emulsion has obvious particles, and insoluble substances precipitate at the bottom
Comparative example 4 It can not be completely dissolved in 20min, and the emulsion has small amount of particles and insoluble precipitate at the bottom
As can be seen from the results in Table 1, the microencapsulated biotin crystals of examples 1 to 9 have the form of nano-microcrystals, and have the advantages of high dissolution and dispersion speed and uniform emulsion after dissolution. The biotin crystals of comparative examples 1 and 4 have large particles and cannot be embedded without grinding or after grinding, and cannot be dissolved in water at normal temperature, and insoluble precipitates are the biotin crystals. Comparative examples 2 and 3 were simply physical mixing, were not microencapsulated, were insoluble in normal temperature water, and had large-particle crystalline precipitates of biotin.
Test example 2
The emulsion of test example 1 was measured for the particle size distribution of oil droplets or insoluble particles in the system using a malvern laser particle size analyzer 3000, and observed under a microscope, and the embedding of the emulsion in the granulation process of the microencapsulation technique was compared and judged, and the results are shown in table 2.
Table 2: oil droplet or insoluble particle distribution of multiple emulsions of each of the examples and comparative examples
Figure BDA0003282316100000211
As can be seen from the results in Table 2, the biotin crystals obtained in examples 1 to 9 were first nano-ground and then microencapsulated, resulting in a small particle size of the emulsion oil droplets, each oil droplet containing tiny biotin crystals, and a good embedding effect. Comparative example 1, which was not ground, the biotin crystal particles were large and biotin could not be embedded, and large biotin crystal particles were tested. Comparative example 2 and comparative example 3 were simply physical mixing, without microencapsulation, and tested as large biotin crystal particles. Comparative example 4 the biotin crystals after milling were not fine enough, the particles were large, most were not encapsulated by oil droplets, the biotin was not completely embedded, and the particle size of the crystal particles was also tested.
Test example 3
Samples of example 1, example 3, example 5 and example 7, and comparative examples 1 to 4 were each placed in a sealed, colorless and transparent vial, and each placed in an ultraviolet aging test chamber (irradiance of 2W/m) 2 25 ℃) and oxygen filling (80 ℃) for 30 days, sampling respectively for 0 day, 10 days, 20 days and 30 days, detecting the content of biotin in each sample by using a high performance liquid chromatograph, and examining the influence of ultraviolet irradiation and oxygen filling high temperature conditions on the content (stability) of biotin in the sample, wherein the results are shown in table 3.
Table 3: influence of ultraviolet irradiation and oxygenation high-temperature conditions on stability of biotin in sample
Figure BDA0003282316100000221
It can be seen from the results in table 3 that the biotin microcapsules obtained by the method of the present invention are placed under the conditions of ultraviolet irradiation and high temperature in oxygen, and accelerated aging is performed, and sampling tests are performed for 0 day, 10 days, 20 days, and 30 days, so that there is substantially no significant drop in the biotin content in the sample microcapsules of examples 1, 3, 5, and 7, and the drop in comparative examples 1 to 4 is significantly large, which indicates that the biotin microcapsules obtained by the method of the present invention have good stability and can prolong the storage time of the biotin active ingredients.
Test example 4
In order to verify that the biotin microcapsules prepared according to the present invention have unique acid resistance, the samples of the above-described examples 1, 3, 5 and 7 and comparative examples 1 to 4 were subjected to a stability test simulating a strong acid environment of gastric juice. Preparing a buffer solution with the pH value of 1.0, dissolving and dispersing 5g of a sample in 200mL of the buffer solution in a closed container with magnetic stirring, keeping the temperature of the solution at 37 +/-0.5 ℃, starting the magnetic stirring (rotating speed of 100 rpm), immediately starting timing, starting a simulated gastric juice digestion experiment, wherein the simulation time is 3h, sampling and detecting at 0, 30min, 60min, 90min, 120min and 180min respectively, and examining the retention rate of biotin content (%), and the results are shown in Table 4.
Table 4: simulating the destruction of the strong acid environment of the stomach to the biotin in the sample
Figure BDA0003282316100000231
As can be seen from the results in Table 4, when the experiment is carried out in a simulated strong acid environment in the stomach, the retention rate of the biotin content of the samples of example 1, example 3, example 5 and example 7 is still high at 3h, and the embedded biotin resists the corrosion of acid substances in the stomach, so that the loss of the biotin content is reduced. And in comparative examples 1-4, the biotin microcapsule prepared by the method provided by the invention is not used or is not completely used, the loss of biotin content of the obtained sample is large under the action of strong acid in the stomach, the sample cannot effectively reach the small intestine, and the bioavailability is reduced.
In conclusion, the biotin microcapsule obtained by the method provided by the invention has better acid resistance, is not damaged in the stomach, and can effectively reach the intestines to be absorbed.
Test example 5
The samples of examples 1, 3, 5 and 7 and comparative examples 1 to 4 were examined for their respective solubilities at different pH values, and the results are shown in Table 5.
Table 5: the reconstitution behavior of the biotin microcapsules under different pH values
Figure BDA0003282316100000241
From the results of table 5, it can be seen that the biotin microcapsule powders of examples 1, 3, 5 and 7 have excellent acid and alkali resistance and can be normally reconstituted in various pH ranges. Comparative examples 1 to 4 were not completely soluble at each pH, the emulsion had significant insoluble particles, bottom precipitates, and poor reconstitution properties.
Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention, and that variations, modifications, substitutions and alterations can be made in the above embodiments by those of ordinary skill in the art without departing from the principle and spirit of the present invention.

Claims (17)

1. The instant nano-scale biotin microcapsule is characterized in that the instant nano-scale biotin microcapsule comprises a capsule core and a capsule wall material, wherein the capsule core is coated in the capsule wall material, the capsule core contains 5-15% of biotin crystals, 20-30% of carrier oil and 0.5-1.5% of oil phase emulsifier by taking the total weight of the instant nano-scale biotin microcapsule as a reference, the carrier oil is vegetable oil and/or fatty acid ester, the capsule wall material contains 20-40% of water phase emulsifying wall material, 10-50% of micromolecular filler, 2-5% of cosolvent and 0.5-1.5% of stabilizer, the crystal particle size of the biotin crystals is less than or equal to 100nm, the molecular weight of the micromolecular filler is less than or equal to 1000, the micromolecular filler is a low-molecular carbohydrate substance, and the stabilizer is at least one selected from sodium hexametaphosphate, potassium tripolyphosphate, trisodium citrate, ethylenediaminetetraacetic acid and sodium salts thereof, ascorbic acid and sodium salts thereof;
the instant nano-scale biotin microcapsule is prepared by the following steps:
s1, stirring and dispersing biotin crystals, an oil phase emulsifier and optional oil-soluble components in pigments and/or essences and fragrances in carrier oil, then grinding until the particle size of the crystals of the biotin crystals is less than or equal to 100nm, and then cooling the system to 0-20 ℃ to obtain an oil suspension I;
s2, stirring and dissolving water-soluble components in the water-phase emulsification wall material, the small-molecule filler, the cosolvent, the stabilizer and the optional pigment and/or essence perfume in water at 50-60 ℃, and then cooling the system to 0-20 ℃ to obtain a water phase II;
s3, mixing and homogenizing the oil suspension I and the water phase II at 0-20 ℃, and adjusting the viscosity to 100-350 mPa & S to obtain an emulsion;
and S4, carrying out spray drying on the emulsion to obtain the instant nano-scale biotin microcapsule.
2. The instant nano-sized biotin microcapsule according to claim 1, wherein said vegetable oil is at least one selected from corn oil, soybean oil, peanut oil, olive oil, sesame oil, sunflower oil, safflower oil, linseed oil, castor oil, cottonseed oil, hemp oil, linseed oil, camellia oil, peony seed oil, palm oil, walnut oil, coconut oil, rice oil and rapeseed oil; the fatty acid ester is at least one selected from caproic acid triglyceride, caprylic acid triglyceride, capric acid triglyceride, caprylic/capric acid triglyceride, heptanoic acid triglyceride and lauric acid triglyceride.
3. The instant nano-scale biotin microcapsule according to claim 1, wherein the oil-phase emulsifier is at least one of sucrose esters having an HLB value of 5 to 7, vitamin E polyethylene glycol succinate, glycerides, and lecithin.
4. The instant nano-scale biotin microcapsule according to claim 1, wherein the emulsifying wall material of the aqueous phase is at least one selected from the group consisting of modified starch, gum arabic, whey protein, sodium caseinate and soy protein isolate.
5. The instant nano-sized biotin microcapsule according to claim 4, wherein the modified starch is at least one selected from the group consisting of acid-modified starch, starch octenylsuccinate, starch sodium octenylsuccinate, oxidized starch, starch acetate, hydroxypropyl starch and pregelatinized starch.
6. The instant nano-sized biotin microcapsule according to claim 1, wherein the small-molecule filler is at least one selected from the group consisting of monosaccharides, disaccharides and oligosaccharides having a molecular weight of 150 to 500.
7. The instant nano-sized biotin microcapsule according to claim 6, wherein said small-molecule filler is at least one selected from the group consisting of glucose, maltose, sucrose, maltodextrin, corn syrup solids and resistant dextrin.
8. The instant nano-scale biotin microcapsule according to claim 1, wherein the co-solvent is at least one selected from the group consisting of glycerol, sorbitol, mannitol, and hexaglycerol laurate.
9. The instant nano-scale biotin microcapsule according to claim 1, further comprising a pigment and/or a flavor, wherein the oil-soluble component of the pigment and the flavor is distributed in the core and the water-soluble component of the pigment and the flavor is distributed in the capsule wall material.
10. The instant nano-sized biotin microcapsule according to claim 1, having a particle size D 90 300 to 500 mu m.
11. The instant nano-sized biotin microcapsule according to claim 1, wherein 1g of the instant nano-sized biotin microcapsule is dissolved in 100mL of water at room temperature to give an emulsion having a particle size distribution D of oil droplets 10 ≤0.15μm，D 50 ≤0.5μm，D 90 ≤1μm。
12. The process for preparing the instant nano-sized biotin microcapsules according to any one of claims 1 to 11, comprising the steps of:
s1, stirring and dispersing biotin crystals, an oil phase emulsifier and optional oil-soluble components in pigments and/or essences and fragrances in carrier oil, then grinding until the particle size of the crystals of the biotin crystals is less than or equal to 100nm, and then cooling the system to 0-20 ℃ to obtain an oil suspension I;
s2, stirring and dissolving water-soluble components in an aqueous phase emulsification wall material, a micromolecular filler, a cosolvent, a stabilizer and optional pigment and/or essence perfume in water at 50-60 ℃ in water, and then cooling the system to 0-20 ℃ to obtain an aqueous phase II;
s3, mixing and homogenizing the oil suspension I and the water phase II at 0-20 ℃, and adjusting the viscosity to 100-350 mPa & S to obtain an emulsion;
and S4, carrying out spray drying on the emulsion to obtain the instant nano-scale biotin microcapsule.
13. The method for preparing the instant nano-scale biotin microcapsules according to claim 12, wherein the step S3 of mixing and homogenizing is performed by mixing the oil suspension I and the water phase II, and then the system temperature is controlled to be 0-20 ℃ and the shearing rotation speed is controlled to be 8000-12000 r/min for shearing and emulsifying for 10-30 min to make the diameter D of oil droplets 90 Less than or equal to 2 mu m, and then homogenizing for 2 to 3 times under the high pressure of 30 to 60MPa to ensure that the grain diameter D of oil drops 90 ≤1μm。
14. The method for preparing the instant nano-scale biotin microcapsules according to claim 12, wherein the spraying is performed in step S4The conditions of the fog drying include the inlet air temperature of 100-180 deg.c, the outlet air temperature of 50-90 deg.c and the inlet air amount of 20-30 m 3 The pressure of the spray tower is 0.1-0.5 KPa.
15. The method for preparing the instant nano-scaled biotin microcapsule according to claim 12, further comprising adding an anti-caking agent to the instant nano-scaled biotin microcapsule after the spray-drying; the anticaking agent is selected from at least one of silicon dioxide, tricalcium phosphate, calcium silicate and microcrystalline cellulose; the dosage of the anticaking agent is not more than 1wt% of the mass of the instant nano-scale biotin microcapsule.
16. Use of the instant nano-scaled biotin microcapsules according to any one of claims 1 to 11 for the preparation of a food additive.
17. Use of the instant nano-scaled biotin microcapsules of any one of claims 1 to 11 for the preparation of a medicament.
CN202111136798.9A 2021-09-27 2021-09-27 Instant nano-scale biotin microcapsule and preparation method and application thereof Active CN113768928B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111136798.9A CN113768928B (en) 2021-09-27 2021-09-27 Instant nano-scale biotin microcapsule and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111136798.9A CN113768928B (en) 2021-09-27 2021-09-27 Instant nano-scale biotin microcapsule and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN113768928A CN113768928A (en) 2021-12-10
CN113768928B true CN113768928B (en) 2023-01-03

Family

ID=78853825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111136798.9A Active CN113768928B (en) 2021-09-27 2021-09-27 Instant nano-scale biotin microcapsule and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN113768928B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114371243A (en) * 2021-12-28 2022-04-19 湖南中晟全肽生化有限公司 HPLC detection method of d-biotin
CN115530356B (en) * 2022-09-23 2023-10-03 江苏四新界面剂科技有限公司 Emulsifying agent for edible essence and preparation method thereof
CN115812824B (en) * 2022-12-13 2024-05-28 南昌大学 Probiotics bursting bead soft sweet and preparation method thereof
CN116138438B (en) * 2023-04-19 2023-07-14 益欣汇盛科技(北京)有限公司 Oil-in-water submicron emulsion system and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106772741B (en) * 2016-12-05 2019-07-23 江南大学 A method of guide mode resonance filtering is realized using single graded material grating

Also Published As

Publication number Publication date
CN113768928A (en) 2021-12-10

Similar Documents

Publication Publication Date Title
CN113768928B (en) Instant nano-scale biotin microcapsule and preparation method and application thereof
Ganesan et al. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery
CA2193497C (en) Controlled release aqueous emulsion
Ni et al. Quercetin loaded nanostructured lipid carrier for food fortification: preparation, characterization and in vitro study
BRPI0613631A2 (en) nanoemulsion, method, and use of a compound and nanoemulsion
BR112021011087A2 (en) COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MANUFACTURE THEREOF
ES2458307T3 (en) Dermatological composition comprising avermectin nanocapsules, their preparation procedure and their use
EA006141B1 (en) Preparation of vitamin emulsions and concentrates thereof
CN100367953C (en) Quercetin solid liposome nano particle preparation and its preparing method
BRPI0704205A2 (en) methods and formulations for enhancing absorption and decreasing absorption variability of orally administered drugs, vitamins and nutrients
WO2016177346A1 (en) Cabazitaxel fat emulsion injection, and preparation method and use thereof
Urimi et al. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery
US20220304948A1 (en) Vitamin k2 microcapsule, preparation method thereof and use thereof in manufacture of medicament for preventing or treating cardiovascular and cerebrovascular diseases
CN111867562A (en) Aqueous formulation of insoluble drugs
JP3996691B2 (en) Emulsified powder and method for producing the same
CN1706371B (en) Efficient sword-like iris seed preparation and its preparation process
Cheng et al. β-Cyclodextrin based Pickering emulsions for α-tocopherol delivery: Antioxidation stability and bioaccessibility
CN101161238A (en) A lipid nanometer microcapsule based on phospholipids and method for preparing the same
KR20220091739A (en) Translucent nanoemulsion containing natural ceramide and cosmetic composition including the same
JP2023522146A (en) Sunflower phospholipid composition containing phosphatidylcholine
Kathpalia et al. Novel oral suspensions: A review
CN101411686A (en) Clarithromycin sub-microemulsion injection and preparation method thereof
US20240066041A1 (en) Microparticles containing stabilized cbd oil, and methods for the production thereof
Drais et al. Investigation of lipid polymer hybrid nanocarriers for oral felodipine delivery: Formulation, method, in-vitro and ex-vivo evaluation
JP2758297B2 (en) Liposome preparation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant